Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Good luck with that one. Masks help reduce the amount of water coming out of the gob, virus transported as an aerosol therefore helps reduce transmission.Particle size of virus particles usually smaller than pore size of mask material but less viral load . Masks are to protect ohers from you and you from others.
Japan sees sense
riotimesonline.com/brazil-news/modern-day-censorship/covid-19-japan-places-myocarditis-warning-on-vaccines-requires-informed-consent/
You know how China is coping with the virus ? They are suing Ivermectin , what Trump said to use in the 1st place.
Even if (jury still out on this) the omicron variant is less virulent ,the problem will be with antivaxers who will cause more disruption to the NHS an other services.
ever
No sure how one defines not a threat. It is a nasty bug that thankfully although the vast majority shall survive, it has a lasting negative impact on many in the guise of Long Covid. From personal experience FF does help with LCV symptoms
https://www.imperial.ac.uk/news/224853/over-million-adults-england-have-long/
W$
Vote on the Vax PP next week , why bother when Omniron is not a threat
https://twitter.com/gnuseibeh/status/1469735787491213312
I quite agree with you Wellsite and Gixer 2 mill FF users would be great and all those on Aspirin should be on FF but as we are seeing big Pharma and Gov's do not care about us , just the money.
Roger that, but we've only had the key patents 5 minutes
Lets hope so if/when momentum builds ,progress has been glacially slow so far with PXS.
Although still contentious, an interesting view
https://academic.oup.com/cid/article/49/9/1405/301441
Market size should increase significantly once By-Health are in a position to sell products and with that will come lower price and greater awareness. Then with lower price and greater awareness comes ....................
Little known fact....
In 1932 100-count bottle of Aspirin cost the equivalent of $16.39 US at 2011 prices.
It was much cheaper a few years later.
Where we are now is approximately 300% up from the low point, where a group of backers decided to take a substantial holdings.
If you think that is bad, perhaps you need to review your own strategy when we could all see those wealthy individuals building their stakes.
Just saying.
Price and awareness as always,market size could be infinite but without the former we would still be where we are now.
An estimated 17.9 million people died from CVDs in 2019
Currently, ˜40 000 tons of aspirin are produced every year worldwide, and in the United States alone, >50 million people take 10 to 20 billion aspirin tablets regularly for the prevention of CVD
What size of market do you need?
https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
https://www.ahajournals.org/doi/full/10.1161/circulationaha.110.963843
A couple of million users worldwide is all we need.......
W£
FF costs me £180 a year , look at this site for info on disposable income . Statements like the remaining 81% of the world needs to know about FF mean nothing , it will never happen as the market is too small . PXS should be doing much much better than it is , that hasn't happened due to lack of advertising which PXS can not afford.
https://www.movehub.com/blog/disposable-income-world-map/
Not sure I agree with your 20% figure there everhopeful were did you get the info?
According to this info only 10% of the world population are classed as poor.
17% of the global population could be considered middle income
15% lived at an upper-middle-income
7% were high income leaving
51% low income.
https://www.pewresearch.org/fact-tank/2021/07/21/are-you-in-the-global-middle-class-find-out-with-our-income-calculator/
The US is maybe not a good comparison to all countries but 77 percent of U.S. adults take dietary supplements.
https://www.crnusa.org/newsroom/dietary-supplement-use-reaches-all-time-high
If Fruitflow is a successful product -does that mean Pxs is successful hooray!
Only about 20% of the world can afford FF and how many of them actually need it ? Anything decent and helpful gets by passed by big pharma , even suppressed in some cases EG GCMAF , David Noakes still in prison.
https://www.ukcolumn.org/article/gcmaf-and-persecution-david-noakes-lyn-thyer-immuno-biotech
At the very least, DSM will be able to supply there existing customers. What else comes out of the DSM negotiations we will just have to wait and see.
gix
good summary. BH Territories cover ~ 19% of the world population. Looking forward to seeing what IF has been doing to cover the remaining 81%. Hopefully companies here would be interested in a similar deal - personally think DSM should be in the mix somewhere but without any exclusivity..
W$
Also good to be mentioned in Pharma related journals.
May even help towards the long term plans????
"(2) During the period of the drug research and development agreement, Provexis and the company will cooperate in drug research and development projects in accordance with the terms of this agreement, and the company has the exclusive right to develop drugs in the area under the agreement."
http://data.eastmoney.com/notices/detail/300146/AN202111051527225504.html
Provexis and By-Health will seek to collaborate on research and development projects which may result in the development and approval of Fruitflow as a drug, for potential sale and distribution in the Territories.
https://otp.investis.com/clients/uk/provexis_plc/rns/regulatory-story.aspx?cid=1569&newsid=1523432
P.S. Nice rise in B-H share price today. Showing 9.34%
Good to be regarded as a successful product.
Another Mention in the pharma world
https://www.sciencedirect.com/science/article/abs/pii/S1043661821005855
https://www.google.co.uk/search?q=fruitflow%22The+current+use+and+evolving+landscape+of+nutraceuticals%22
2
4 Nov 2021 — The Current Use and Evolving Landscape of Nutraceuticals ... One such example of a successful product is Fruitflow® manufactured by Provexis ...
to be published in a pharma journal next month
https://www.sciencedirect.com/journal/pharmacological-research
About the journal
Formerly known as Pharmacological Research Communications;
Pharmacological Research publishes cutting-edge articles in biomedical sciences to cover a broad range of topics that move the pharmacological field forward. We provide a venue through which specialists across disciplines can rapidly exchange information in health sciences that pertains to modern …
Barbershop,
RE: but it wouldn't rule out us buying from DSM and them handling logistics to ship to China
Although a possibility I don't think that is the plan.
"The Agreement for Fruitflow announced today between the Company and By-Health falls under (ii) above, with the Company set to sell Fruitflow as an ingredient directly to By-Health from 1 January 2023; 100% of the Company's sales of Fruitflow to By-Health will accrue directly to the Company, and the Company will retain all of the resulting profits."
The company (PXS) is already in negotiations with the third party manufacturers.
"The Company and the third party manufacturers are actively engaged in some ongoing production capacity planning, looking at the steps required to scale-up the production of Fruitflow to meet the anticipated increase in demand."
Its a win win situation for Provexis and probably for By-Health as well as we could supply them with a cheaper product price and still come out with a higher profit.
Just in my opinion though.